Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303K Sell
12,032
-212,200
-95% -$4.77M 0.67% 27
2026
Q1
$4.24M Buy
224,232
+15,000
+7% +$284K 1.44% 20
2025
Q4
$3.86M Sell
209,232
-179,200
-46% -$3.16M 1.37% 23
2025
Q3
$7.07M Buy
388,432
+12,862
+3% +$223K 2.45% 15
2025
Q2
$6.08M Sell
375,570
-53,130
-12% -$819K 2.07% 23
2025
Q1
$7.36M Buy
428,700
+58,250
+16% +$1.11M 2.39% 18
2024
Q4
$7.38M Buy
+370,450
New +$7.23M 2.4% 20

Other funds holding MAC

B&I Capital's MAC Position: Q2 2026 in Review

B&I Capital reduced its Macerich (MAC) stake by 95% in Q2 2026, selling an estimated $4.77M and leaving 12,032 shares worth $303K. The position accounts for 0.67% of the portfolio, ranked #27.

B&I Capital first reported a position in MAC in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.38M in Q4 2024. 348 funds tracked by Wall St. Rank hold MAC as of Q2 2026.

  • B&I Capital held 12,032 shares of Macerich worth $303K as of Q2 2026.
  • B&I Capital sold 212,200 Macerich shares in Q2 2026, an estimated $4.77M.
  • Macerich made up 0.67% of B&I Capital's portfolio in Q2 2026, its #27 holding.
  • B&I Capital first reported a position in Macerich in Q4 2024 and has held it in 7 quarters since.
  • B&I Capital's Macerich position peaked at $7.38M in Q4 2024.
  • 348 funds tracked by Wall St. Rank held Macerich as of Q2 2026.

Based on B&I Capital's 13F filing for Q2 2026, filed 11 Aug 2026.